¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Alpha Lipoic Acid Oral"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • saturated fatty acid
    Æ÷È­Áö¹æ»ê
  • sorbic acid
    ¼Ò¸£ºê»ê
  • spermanucleic acid
    Á¤ÀÚÇÙ»ê
  • stearic acid
    ½ºÅ׾Ƹ£»ê
  • succinic acid
    ¼÷½Å»ê
  • sugar acid
    ´ç»ê
  • sulfuric acid
    Ȳ»ê
  • sulfurous acid
    ¾ÆÈ²»ê
  • salicylic acid
    »ì¸®½Ç»ê
  • sialic acid
    ½Ã¾Ë»ê
  • taurocholic acid
    Ÿ¿ì·ÎÄÝ»ê
  • teichoic acid
    Å×ÀÌÄÚ»ê
  • teichuronic acid
    Å×ÀÌÅ¥·Ð»ê
  • tannic acid
    ź´Ñ»ê
  • tartaric acid
    Ÿ¸£Å¸¸£»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • hydrofluoric acid
    ºÒÈ­ ¼ö¼Ò»ê(Ý×ûù â©áÈß«)
  • hydroparacumaric acid
    È÷µå·ÎÄí¸¶¸°»ê.
  • hydroxamic acid
    È÷µå·Ï»ï»ê(¡­ß«).
  • hydroxyindoleacetic acid = 5-HIAA
    5-ÇÏÀ̵å·Ï½ÃÀε¹ÃÊ»ê
  • indoxyl carbonic acid ester
    Àε¶½Çź»ê¿¡½ºÅ׸£
  • inosinic acid
    À̳ë½Å»ê.
  • phocenic acid
    ±æÃÊ»ê(ÑÎõ³ß«).
  • phosphopyruvic acid
    Æ÷½ºÆ÷ÇǺ긣»ê.
  • phosphotungstic acid hematoxylin =ptah
    ÀÎ(ìÝ)ÅÖ½ºÅÙ»êÇ츶Åå½Ç¸°
  • picramic acid
    ÇÇÅ©¶÷»ê(¡­ß«).
  • polyunsaturate fatty acid
    ´Ù(Òý)ºÒÆ÷È­Áö¹æ»ê.
  • propionic acid
    ÇÁ·ÎÇǿ»ê(¡­ß«).
  • prostatic acid phosphatase
    Àü¸³¼±»êÀλêÈ¿¼Ò(Æ÷½ºÆÄŸÁ¦)(îñí¡àÍß«×òß«ý£áÈ)
  • pteroylmonoglutamic acid
    Å×·ÎÀϸð³ë±Û·çŽ»ê(¡­ß«)
  • pyridoxic acid
    ÇǸ®µ¶½Å»ê(¡­ß«).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • oral sadism
    ±¸°­°¡ÇоÖ(Ϣ˷ʥùËäñ).
  • oral self cleaning action
    ±¸°­ÀÚÁ¤ÀÛ¿ë(Ϣ˷í»ïäíÂéÄ).
  • oral sepsis
    ±¸°­ºÎÆÐÁõ(Ϣ˷ݯø¨ñø).
  • oral soft tissue
    ±¸°­¿¬ºÎÁ¶Á÷(Ϣ˷ҴݷðÚòÄ)
  • oral soft tissue,erythroplakia
    È«»öÆÇ(ûõßä÷ù), Àû»ö¹Ý(îåßäÚè)
  • oral stage
    ±¸°­±â(Ϣ˷Ѣ).
  • oral surgeon
    ±¸°­¿Ü°úÀÇ(Ϣ˷èâΡì¢).
  • oral surgery
    ±¸°­¿Ü°ú(ÇÐ)(Ϣ˷èâΡùÊ).
  • oral temperature
    ±¸°­¿Âµµ(Ϣ˷è®öô).
  • oral thrush
    ¾Æ±¸Ã¢
  • oral tissue
    ±¸°­Á¶Á÷(Ϣ˷ðÚòÄ).
  • oral tuberculosis
  • oral tumor
    ±¸°­Á¾¾ç(Ϣ˷ðþåË).
  • oral tumor
    ±¸°­Á¾¾ç(Ϣ˷ðþåË)
  • oral ulcers
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • nicotinic acid
    ´ÏÄÚÆ¾»ê(ß«)
  • nicotinic acid amide
    ´ÏÄÚÆ¾»ê(ß«) ¾Æ¸¶À̵å
  • nitrous acid
    ¾ÆÁú»ê(ä¬òòß«)
  • nitrous acid mutant
    ¾ÆÁú»êº¯ÀÌü(ä¬òò߫ܨì¶ô÷)
  • nonionized acid
    ºñ(Þª)ÀÌ¿ÂÈ­(ûù) »ê(ß«)
  • nonnucleic acid base
    ºñÇÙ»ê ¿°±â(Þªú·ß«ç¤Ðñ)
  • nonpolar amino acid
    ¹«±Ø¼º(Ùíпàõ) ¾Æ¹Ì³ë»ê(ß«)
  • nonprotein amino acid
    ºñ´Ü¹éÁú(ÞªÓ±ÛÜòõ) ¾Æ¹Ì³ë»ê(ß«)
  • nucleic acid
    ÇÙ»ê(ú·ß«)
  • nucleic acid bases
    Çٻ꿰±â(ú·ß«ç¤Ðñ)
  • odd-numbered fatty acid
    Ȧ¼ö Áö¹æ»ê(ò·Û¸ß«)
  • oleic acid
    ¿Ã·¹»ê(ß«)
  • orotic acid
    ¿À·Îƾ»ê
  • orotidylic acid
    ¿À·ÎƼµô»ê(ß«)
  • palmitic acid
    ÆÈ¹ÌÆ®»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
ORALABX oral antibiotics
ORD optical rotatory dispersion; oral radiation death
OROS oral osmotic
ORT object relations technique; operating room technician; oral rehydration therapy
OS left eye [Lat. oculus sinister]; occipitosacral; occupational safety; office surgery; Omenn syndrome...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
alpha 1-PI Alpha 1-proteinase inhibitor
alpha 2-AP alpha 2-antyplasmin
alpha 2-M Alpha 2-Macroglobulin
alpha 2PI Alpha 2-plasmin inhibitor
alpha-ANP Alpha atrial natriuretic peptide
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • para- : ºÎ, ÁÖÀ§, ¹æ, ±Ù, ±Ù»ç, ¿ø ¹× ÀÌ µîÀÇ ¶æÀ» ³ªÅ¸³»´Â Á¢µÎ¾î.

    para-amino salicylic acid

    ÆÄ¶ó-¾Æ¹Ì³ë »ì¸®½Ç »ê
    ÇÕ¼ºµÈ Ç×°áÇÙ ¾àÀ¸·Î Ç×±Õ ÀÛ¿ëÀº °áÇÙ ±Õ¿¡ ƯÀÌÀûÀÌ¸ç ´Ù¸¥ º´¿ø ±Õ¿¡ ÀÛ¿ëÇÏÁö ¾Ê´Â´Ù. È­ÇÐ ±¸Á¶´Â »ì¸®½Ç »ê°ú À¯»çÇϳª ÁßÃß ½Å°æ°è¿¡ ´ëÇÑ ÀÛ¿ëÀº °ÅÀÇ ¾ø´Ù. ÀÛ¿ë ±âÀüÀº ¸íÈ®ÇÏÁö ¾ÊÀ¸¸ç ´ë»ç ±æÇ×Á¦, È£Èí »ê¼Ò ÀúÇØ¼³ÀÌ ÀÖ´Ù. ½ÃÇè°ü ³»ÀÇ Ç×±Õ ÀÛ¿ëÀº °­ÇÏÁö¸¸ Ç׿°Àº ¾ÆÀ̼ҳªÀ̾ÆÁö, ½ºÆ®·¾Å丶À̽ź¸´Ù ¾à°£ ¾àÇÏ¸ç ´ë·®ÀÇ º¹¿ëÀ» ¿äÇÑ´Ù. ½ºÆ®·¾Å丶À̽ź¸´Ù ³»¼º ÃâÇöÀÌ ´Ê´Ù. ´Üµ¶º¸´Ù ½ºÆ®·¾Å丶À̽Å, ¾ÆÀ̼ҳªÀ̾ÆÁöµå¿ÍÀÇ º´¿ëÀº È¿°ú Áõ°­°ú ³»¼º ¹ßÇöÀÇ Áö¿¬È­¸¦ ³ë¸°´Ù. µ¶¼ºÀº ÀÛÀ¸¸ç ºÎÀÛ¿ëÀÇ ÁÖµÈ °ÍÀº ¼ÒÈ­°ü¿¡ ´ëÇÑ ±¹¼Ò Àڱؿ¡ ÀÇÇÑ °Í
  • paraaminohippuric acid
    ÆÄ¶ó ¾Æ¹Ì³ë¸¶´¢»ê, ÆÄ¶ó ¾Æ¹Ì³ëÈ÷Ǫ¸£»ê
    ¾Æ¹Ì³ë ¾È½ÄÇâ»êÀÇ N-ÃÊ»ê. C
  • pentonic acid
    ÆæÅæ»ê
  • performic acid
    °úÀÇ»ê
    cysteinÀ» »êÈ­ÇÏ¿© cysteic acid·Î ÇÏ¿© ÆéŸÀ̵åÀÇ disulfide °áÇÕÀ» Âɰ³±â À§ÇÏ¿© »ç¿ëµÇ´Â À¯±â°ú»ê¼Ò»ê.
  • permanganic acid
    °ú¸Á°£»ê
    ÀÏ ¿°±â»ê. Áö¼ÓÀûÀÎ ½ÉÈ«»öÀ» °®´Â´Ù.
  • phosphoric acid
    Àλê
    ¿À»êÈ­ÀÎ PO°¡ ¼öÈ­ÇÏ¿© »ý±â´Â ÀÏ·ÃÀÇ »ê mPO, nHOÀÇ ÃÑĪ. ¸ÞŸ Àλê, ÇÇ·Î Àλê, ¿À¸£Åä Àλê, »ïÀλê, »çÀÎ»ê µîÀÌ ÀÖ°í, ÀÌ ¹Û¿¡ ¸ÞŸ ÀλêÀÇ ÁßÇÕ¿¡ ÀÇÇØ¼­ »ý±â´Â Æú¸® ¸ÞŸ ÀλêÀÇ °è¿­µµ ÀÖÀ¸³ª, ÀϹÝÀûÀ¸·Î´Â ¿À¸£Åä ÀλêÀ» °¡¸®Å²´Ù. ÀλêÀÇ ¼ºÁúÀº ¹«»ö, ¹«ÃëÀÇ Á¡¼ºµµ°¡ Å« ¾×üÀ̸ç, ³óµµ°¡ ³ô¾ÆÁö¸é °áÁ¤È­Çϱ⠽±´Ù. ³ì´ÂÁ¡ 42.35 ¡É, ºñÁß 1.834ÀÌ´Ù. Á¶ÇؼºÀÌ ÀÖ°í, 100 gÀÇ ¹°¿¡ 20 ¡É¿¡¼­ 542 g ³ì´Â´Ù. ºñÈֹ߼ºÀÌ¸ç °¡¿­Çϸé ÇÇ·Î ÀλêÀ̳ª Æú¸® ÀλêÀÌ µÇ°í, ´õ °¡¿­ÇÏ¸é ¸ÞŸ ÀλêÀÌ µÈ´Ù. ¾ËÄڿÿ¡µµ ³ì´Â´Ù. ±Ý¼Ó ¹× ±× »êÈ­¹°À» °Ý·ÄÇÏ°Ô Ä§½ÄÇÑ´Ù. ÀϹÝÀûÀ¸·Î »ýü ³»¿¡¼­´Â Àλê ÇüÅ·Î, »ý¹°°è¿¡¼­´Â Àλ꿰 ¶Ç´Â ÀÎ»ê ¿¡½ºÅ׸£ÀÇ ÇüÅ·ΠÇÙ»ê, ÀÎ ´Ü¹éÁú, ÀÎ ÁöÁú µî »ýüÀÇ ÁÖ¿ä ±¸¼º ¼ººÐÀ» Çü¼ºÇÑ´Ù. °í¿¡³ÊÁö ÀÎ»ê °áÇÕÀ» ¸¸µé¾î ¿¡³ÊÁö ¿î¹ÝüÀÇ ±¸½ÇÀ» ÇÏ´Â µî, »ýÈ­Çлó Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù.
  • polyacrylic acid
    Æú¸® ¾ÆÅ©¸±¸¯ »ê
  • polyenic acid
    Æú¸®¿£»ê
    ź¼ÒüÀÇ ÀÌÁß °áÇÕÀÌ µÎ°³ ÀÌ»ó Á¸ÀçÇÏ´Â Áö¹æ»ê.
  • polyunsaturate fatty acid
    ´ÙºÒÆ÷È­ Áö¹æ»ê
  • pyrophosphoric acid
    ÇÇ·ÎÀλê
    ¿À¸£Åä ÀλêÀ» 200-300µµ·Î ¿À·¡ °¡¿­ÇÒ ¶§ »ý±â´Â Å« °áÁ¤.
  • pyruvic acid
    ÆÄÀÌ·çºó»ê, Ãʼº Æ÷µµ»ê
    ź¼öÈ­¹° ´ë»çÀÇ Áß°£ ¹°Áú. ¶ó½Ã¹Ì »êÀ̳ª ÁÖ¼®»êÀÇ °Ç·ù¿¡ ÀÇÇØ »ý¼ºµÉ ¼ö ÀÖ´Ù.
  • quinaldinic acid
    Ű³¯µò»ê
  • quinolinic acid
    Ű³î¸°»ê
    ¹«»öÀÇ ÁÖ»ó °áÁ¾À¸·Î, Ű³î¸°ÀÇ »êÈ­ »ý¼º¹°.
  • ribonucleic acid
    ¸®º¸ ÇÙ»ê
    È¿¸ð¿¡¼­ óÀ½À¸·Î ºÐ¸®µÈ ÇÙ»êÀ¸·Î ³ªÁß¿¡´Â ¸ðµç »ì¾ÆÀÖ´Â ¼¼Æ÷¿¡¼­µµ ¹ß°ßµÇ¾ú´Ù. °¡¼öºÐÇØÇÏ¸é ¾Æµ¥´Ñ, ±¸¾Æ´Ñ, »çÀÌÅä½Å, ¿ì¶ó½Ç, ¶ûº¸½º, ÀλêÀÌ »ý±ä´Ù. RNA¶ó ¾à±âÇÑ´Ù.
  • saccharic acid
    »çÄ«¸°»ê, ´ç»ê, »èÄ«¸°»ê
    1. ÀÌ¿°±â»ê. COOH,
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
mannosyl-oligosaccharide 1,2-alpha-mannosidase <enzyme> Cleaves off terminal alpha-1,2-linked mannose residues resulting in the oligosaccharide man(9)glcnac(2)
Registry number: EC 3.2.1.113
Synonym: alpha-d-mannosidase I, mannosidase I, man9-mannosidase, man9-alpha-mannosidase, alpha 1,2-mannosidase, 1,2-alpha-d-mannosidase, msds protein
(26 Jun 1999)
mannosyl-oligosaccharide 1,3 - 1,6-alpha-mannosidase <enzyme> Removes alpha-1,3- and alpha-1,6-mannosyl residues during post-translational modification of glycoproteins; amino acid sequence of gmii (drosophila) given in second source; genbank x77652
Registry number: EC 3.2.1.114
Synonym: mannosidase II, alpha-d-mannosidase II, 1,3-(1,6-)mannosyl-oligosaccharide alpha-d-mannohydrolase, golgi alpha-mannosidase II, gmii gene product
(26 Jun 1999)
gene rearrangement, alpha-chain T-cell antigen receptor Ordered rearrangement of T-cell variable gene regions coding for the alpha-chain of antigen receptors.
(12 Dec 1998)
genes, T-cell receptor alpha DNA sequences encoding the alpha chain of the T-cell receptor. The genomic organization of the tcr alpha genes is essentially the same in all species and is similar to the organization of ig genes.
(12 Dec 1998)
receptors, adrenergic, alpha One of the two major pharmacological subdivisions of adrenergic receptors. The alpha-beta distinction was originally based on cellular effects of receptor activation but now relies on the relative affinities for certain synthetic ligands. Alpha-adrenergic receptors are further subdivided into several subclasses based on studies of endogenous and cloned receptors.
(12 Dec 1998)
receptors, adrenergic, alpha-1 A subclass of alpha-adrenergic receptors (receptors, adrenergic, alpha). Alpha-1 adrenergic receptors can be pharmacologically discriminated, e.g., by their high affinity for the agonist phenylephrine and the antagonist prazosin. They are widespread, with clinically important concentrations in the liver, the heart, vascular, intestinal, and genitourinary smooth muscle, and the central and peripheral nervous systems.
(12 Dec 1998)
receptors, adrenergic, alpha-2 A subclass of alpha-adrenergic receptors (receptors, adrenergic, alpha). Alpha-2 adrenergic receptors can be pharmacologically discriminated, e.g., by their high affinity for the agonist clonidine and the antagonist yohimbine. They are found on pancreatic beta cells, platelets, and vascular smooth muscle, as well as both pre- and postsynaptically in the central and peripheral nervous systems.
(12 Dec 1998)
receptors, antigen, T-cell, alpha-beta T-cell receptors composed of CD3-associated alpha and beta polypeptide chains and expressed primarily in CD4+ or CD8+ T-cells. Unlike immunoglobulins, the alpha-beta T-cell receptors recognise antigens only when presented in association with major histocompatibility (MHC) molecules.
(12 Dec 1998)
maternal serum alpha-fetoprotein A plasma protein, alpha-fetoprotein (afp) is normally produced by the foetus. The level of afp in the blood serum of pregnant women provides a screening test for open neural tube defects (anencephaly and spina bifida) and for down syndrome (and other chromosome abnormalities). The maternal serum afp (msafp) tends to be unusally high with open neural tube defects and unsually low with down syndrome.
(12 Dec 1998)
glucan 1,4-alpha-glucosidase <enzyme> An enzyme that catalyses the hydrolysis of terminal 1,4-linked alpha-d-glucose residues successively from non-reducing ends of polysaccharide chains with the release of beta-glucose. It is also able to hydrolyze 1,6-alpha-glucosidic bonds when the next bond in sequence is 1,4.
Chemical name: 1,4-alpha-D-Glucan glucohydrolase
Registry number: EC 3.2.1.3
(12 Dec 1998)
glucan 1,4-alpha-maltohexaosidase <enzyme> From klebsiella pneumoniae; hydrolyzes 1,4-alpha-d-glucosidic linkages in amylaceous polysaccharides so as to remove successive maltohexaose residues from the non-reducing ends
Registry number: EC 3.2.1.98
Synonym: exo-maltohexao-hydrolase, extracellular maltohexaose-forming amylase, bacillus maltohexaose-forming amylase, g6-amylase
(26 Jun 1999)
glucan 1,6-alpha-isomaltosidase <enzyme> Hydrolyzes 1,6-alpha-d-glucosidic linkages in polysaccharides so as to remove successive isomaltose units from the non-reducing ends of the chains; from arthrobacter globiformis; mw 66 kD; genbank d30761
Registry number: EC 3.2.1.94
Synonym: isomalto-dextranase, 1,6-alpha-d-glucan isomaltohydrolase, imd gene product, exo-isomaltohydrolase
(26 Jun 1999)
cephalosporin 7-alpha-hydroxylase <enzyme> A dioxygenase from streptomyces clavuligerus; requires 2-oxoglutarate, fe2+ and a reducing agent such as ascorbic acid
Registry number: EC 1.14.11.-
(26 Jun 1999)
glycopeptide alpha-N-acetylgalactosaminidase <enzyme> Hydrolyzes terminal d-galactosyl-n-acetyl-alpha-d-galactosaminide residues from glycopeptides and glycoproteins linked by serine or threonine residues
Registry number: EC 3.2.1.97
Synonym: o-glycanase
(26 Jun 1999)
glycoprotein endo-alpha-1,3-mannosidase <enzyme> An endomannosidase; cleaves glucosyl alpha1-3-mannose from monoglucosylated oligosaccharide (glcman(7-9)glcnac) of the glycoprotein produced in the golgi membrane
Registry number: EC 3.2.1.130
Synonym: glucosyl mannosidase
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
ÅëÇÕ°Ë»ö ¿Ï·á